Skip to content
Search

Latest Stories

No medicines contracts for suppliers who do not submit evergreen assessment from 2024, says NHSE

The introduction of the evergreen assessment is part of NHS England's ambition to reach carbon net zero by 2045 

Starting from January 2024, it will be compulsory for medicine suppliers in the NHS supply chain in England to submit an Evergreen Sustainable Supplier Assessment each year.


Suppliers who fail to submit the sustainability assessment will not be placed on medicines contracts, said NHS England. 

The NHS has taken this move as part of its ambition to reach carbon net zero by 2045.

The Evergreen Sustainable Supplier Assessment is a self-assessment and reporting tool for suppliers to share sustainability information with the NHS.

Chris McAleer, medicines net zero project delivery manager at NHS England, announced this new rule at the Guild of Healthcare Pharmacists’ Procurement and Distribution Interest Group Autumn Symposium held in Birmingham on 2 November 2023.

As quoted in the Pharmaceutical Journal, McAleer said: “Across all NHS England medicines procurements, you [the supplier] will be required to submit an evergreen assessment.

“If you [the supplier] do not have a submission, you will not proceed on further in that procurement process and won’t be able to get placed on an NHS England medicines framework or contract.

“The way that we’re going to be monitoring KPIs [key performance indicators] with this, is that during the life of a framework or contract, if you lapse in not having a submission, we will treat that as a breach of contract capable of remedy,” he added.

After receiving their evergreen assessment, the suppliers will be assessed against four maturity levels to check if they align with NHS sustainability priorities.

However, McAleer stated that NHS England is not asking for a level from the suppliers, but to submit.

“The reason we’re doing that is because we understand suppliers are different parts on their journey. Not everyone is going to be at the top level, some people might still be collating information to put any information in there at all.

“This is why we want a submission, and it’s going to be a pass or fail,” he added, as quoted by the Royal Pharmaceutical Society's official journal.

Medicine suppliers’ reactions

The Association of the British Pharmaceutical Industry (ABPI) informed the journal that it has worked with the Greener NHS programme to develop the evergreen assessment.

The ABPI believes that the assessment will allow companies/suppliers to engage consistently and through a single route with the NHS to reach “the overall net-zero targets and timelines.”

Further, the Association informed that they are committed to meeting the requirements.

Martin Sawyer, executive director at the Healthcare Distribution Association (HDA), which represents medicines wholesalers, said that its members support the NHS net-zero agenda.

He mentioned that the NHS net-zero agenda will “present bigger challenges when it begins to include primary care in the future.”

According to Sawyer, HDA members have started calculating their respective carbon emissions footprint for their part of this journey for each medicine pack.

“This calculation will then be communicated to each manufacturer whose products the particular wholesaler or 3PL [third party logistics companies] stores and distributes,” he told the Pharmaceutical Journal.

Medicines account for 25 per cent of emissions within the NHS

NHS England and NHS Improvement are determined to become the world’s first “net-zero” national health service.

A report published by them in October 2020 highlighted two targets: to reach net zero by the year 2040 for carbon emissions the NHS controls directly, and by 2045 for emissions the NHS influences but does not directly control.

As per the report, medicines accounted for 25 per cent of emissions within the NHS.

Anaesthetic gases account for 2 per cent of emissions, while propellant gases from inhalers account for 3 per cent of emissions.

More For You

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less